Replies to post #9633 on Globe Photos Inc (fka GBPT)

[VERYLONGSTOPPEDDRINKINGTHEKOOLAID]

Here is Mike's post from RB:

By: mikew010173
22 Sep 2006, 04:17 PM EDT
Msg. 4550 of 4550
Jump to msg. #
If in fact the forward book does come to fruition:

By end of December 31, 2006 we will have 7,750 units being billed (according to forward book statement). That comes to about 7.4 million revenues and 5 million income before extraordinary events and taxes (again, using their margin rate).

5 million NIBT at 9.7 million outstanding shares is .52 cents a share.

At that time, Nasdaq listing should start to be pursued as the growing company will have financial stability to warrant it going forward.

Nasdaq translation for a company at these early of a stage in market penetration easily warrants a PE of between 50 and 150. Lets be conservative and use 50.

With only a UK market penetration of 3.5% and global penetration of about a half a percent ( 0.5%) - Medify will already be commanding a share price of 26 bucks a share.

Also IMO, there will be potential, at that stage, for a buyout. Obviously larger companies will want to wait and see that Medify does indeed get their first solid foot down and established, but will also NOT want to wait to long before Medify gets too established, and the buyout price will rocket too high if they wait too long. IMO, at the point displyed above, a 'big dawg' may offer Medify anywhere between 30 and 100 dollars a share for the majority shares.

All of these are real scenarios if and only if the forward book is in fact true. Isn't it worth the risk of 75 cents though? The reward at these prices far exceeds the risk IMO. And far is not nearly strong enough of a term.